$AREB
AMERICAN REBEL HOLDINGS INC Stock $areb

$areb Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000149315224014473 Filed on April 12, 2024

Income Statement

Concept	2024 Q2	2023 Q4	2023
Revenue	$3.255M	$4.810M	$16.23M
YoY Change	-11.31%	24.8%	92.06%
Cost Of Revenue	$3.225M	$4.322M	$13.19M
YoY Change	8.12%	41.86%	102.66%
Gross Profit	$30.66K	$487.6K	$3.036M
YoY Change	-95.54%	-39.6%	56.48%
Gross Profit Margin	0.94%	10.14%	18.71%
Selling, General & Admin	$3.310M	$3.276M	$9.466M
YoY Change	62.21%	331.19%	66.1%
% of Gross Profit	10799.12%	671.88%	311.76%
Research & Development	$337.8K	$426.0K	$1.406M
YoY Change		-43.84%	88.19%
% of Gross Profit	1101.85%	87.37%	46.29%
Depreciation & Amortization	$30.68K	$24.97K	$104.2K
YoY Change	21.36%	-35.61%	108.1%
% of Gross Profit	100.08%	5.12%	3.43%
Operating Expenses	$3.979M	$3.727M	$10.98M
YoY Change	77.72%	139.36%	56.72%
Operating Profit	-$3.948M	-$3.240M	-$7.940M
YoY Change	154.57%	332.03%	56.81%
Interest Expense	-$1.055M	-$154.8K	-$402.5K
YoY Change	-810.79%	895.5%	-212.21%
% of Operating Profit
Other Income/Expense, Net	-$1.305M	$5.670K	$1.113M
YoY Change	-217.82%
Pretax Income	-$5.253M	-$7.490M	-$11.10M
YoY Change	790.03%	878.53%	55.4%
Income Tax		$0.00	$0.00
% Of Pretax Income
Net Earnings	-$5.253M	-$7.490M	-$11.10M
YoY Change	790.03%	878.53%	55.4%
Net Earnings / Revenue	-161.36%	-155.71%	-68.4%
Basic Earnings Per Share	-$0.89		-$3.81
Diluted Earnings Per Share	-$0.89	-$1.02	-$3.81
COMMON SHARES
Basic Shares Outstanding	5.948M shares	5.020M shares	2.912M shares
Diluted Shares Outstanding	5.880M shares		2.912M shares

Balance Sheet

Concept	2024 Q2	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$452.8K	$1.148M	$1.148M
YoY Change	-83.43%	221.71%	221.71%
Cash & Equivalents	$452.8K	$1.148M	$1.148M
Short-Term Investments
Other Short-Term Assets	$191.6K	$190.9K	$190.9K
YoY Change	19.53%	-7.79%	-7.79%
Inventory	$6.357M	$6.103M	$6.103M
Prepaid Expenses	$191.6K	$190.9K
Receivables	$2.144M	$2.817M	$2.817M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$9.460M	$10.26M	$10.26M
YoY Change	-31.2%	3.53%	3.53%
LONG-TERM ASSETS
Property, Plant & Equipment	$310.8K	$2.307M	$2.307M
YoY Change	-22.72%	405.35%	-5.21%
Goodwill	$2.000M	$2.000M
YoY Change	-52.38%	-52.38%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$3.392M	$83.40K	$83.40K
YoY Change	-40.67%	-98.65%	362.56%
Total Long-Term Assets	$3.703M	$4.390M	$4.390M
YoY Change	-39.49%	-34.0%	-34.0%
TOTAL ASSETS
Total Short-Term Assets	$9.460M	$10.26M	$10.26M
Total Long-Term Assets	$3.703M	$4.390M	$4.390M
Total Assets	$13.16M	$14.65M	$14.65M
YoY Change	-33.75%	-11.54%	-11.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.453M	$1.979M	$1.979M
YoY Change	7.15%	-21.59%	-21.59%
Accrued Expenses	$1.204M	$1.310M	$1.310M
YoY Change	12.62%	19.49%	19.49%
Deferred Revenue
YoY Change
Short-Term Debt	$3.732M	$3.456M	$3.456M
YoY Change	151.73%	473.55%	473.56%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$10.12M	$6.745M	$6.745M
YoY Change	59.48%	59.74%	59.74%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$521.6K	$907.5K	$907.5K
YoY Change	-0.02%	-7.85%	-7.85%
Total Long-Term Liabilities	$521.6K	$907.5K	$907.5K
YoY Change	-0.02%	-7.85%	-7.85%
TOTAL LIABILITIES
Total Short-Term Liabilities	$10.12M	$6.745M	$6.745M
Total Long-Term Liabilities	$521.6K	$907.5K	$907.5K
Total Liabilities	$10.64M	$7.653M	$7.653M
YoY Change	54.96%	46.96%	46.96%
SHAREHOLDERS EQUITY
Retained Earnings	-$53.17M	-$45.21M
YoY Change	52.21%	32.54%
Common Stock	$5.880K	$9.005K
YoY Change	685.05%	-46.81%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.520M	$6.996M	$6.996M
YoY Change
Total Liabilities & Shareholders Equity	$13.16M	$14.65M	$14.65M
YoY Change	-33.75%	-11.54%	-11.54%

Cashflow Statement

Concept	2024 Q2	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$5.253M	-$7.490M	-$11.10M
YoY Change	790.03%	878.53%	55.4%
Depreciation, Depletion And Amortization	$30.68K	$24.97K	$104.2K
YoY Change	21.36%	-35.61%	108.1%
Cash From Operating Activities	-$1.789M	-$946.8K	-$7.036M
YoY Change	128.14%	5.11%	3.05%
INVESTING ACTIVITIES
Capital Expenditures	$5.940K	$6.300K	$6.300K
YoY Change		-12.98%	-69.84%
Acquisitions
YoY Change
Other Investing Activities		-$51.40K	-$325.0K
YoY Change			-96.83%
Cash From Investing Activities	-$6.350K	-$57.70K	-$331.3K
YoY Change	-553.57%	696.96%	-96.77%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$5.304M
YoY Change			-44.77%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.574M	519.0K	8.158M
YoY Change	-48.41%	555.23%	-53.21%
NET CHANGE
Cash From Operating Activities	-1.789M	-946.8K	-7.036M
Cash From Investing Activities	-6.350K	-57.70K	-331.3K
Cash From Financing Activities	1.574M	519.0K	8.158M
Net Change In Cash	-222.1K	-485.5K	790.9K
YoY Change	-109.8%	-41.42%	133.21%
FREE CASH FLOW
Cash From Operating Activities	-$1.789M	-$946.8K	-$7.036M
Capital Expenditures	$5.940K	$6.300K	$6.300K
Free Cash Flow	-$1.795M	-$953.1K	-$7.042M
YoY Change		4.97%	2.82%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent		usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense		usd
CY2023	AREB	Interest Expense Preemptive Rights Release InterestExpensePreemptiveRightsRelease		usd
CY2022	AREB	Employee Retention Credit Funds Net Of Costs To Collect EmployeeRetentionCreditFundsNetOfCostsToCollect		usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2022	AREB	Tangible Asset Valuation Adjustment TangibleAssetValuationAdjustment		usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2023	AREB	Stock Issued During Period Value Reverse Stock Splits StockIssuedDuringPeriodValueReverseStockSplits		usd
CY2022	AREB	Compensation Paid Through Issuance Of Common Stock Related Parties CompensationPaidThroughIssuanceOfCommonStockRelatedParties		usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
CY2022	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense		usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2022	AREB	Inventory Adjustment InventoryAdjustment		usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable		usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2022	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants		usd
CY2022	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit		usd
CY2022	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit		usd
CY2022	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt		usd
CY2023	AREB	Repayments Of Non Related Party Debt RepaymentsOfNonRelatedPartyDebt		usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022	us-gaap	Stock Issued1 StockIssued1		usd
CY2022	AREB	Modification Of Conversion Terms ModificationOfConversionTerms		usd
CY2023	AREB	Debt Repayment Through Issuance Of Common Stock DebtRepaymentThroughIssuanceOfCommonStock		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent		usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue		usd
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2022	AREB	Share Based Compensation Arrangement By Share Based Payment Award Options Expired In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriodTotalIntrinsicValue		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue		usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2023	AREB	Share Based Compensation Arrangement By Share Based Payment Award Options Expired In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriodTotalIntrinsicValue		usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization		usd
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization		usd
CY2023	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense		usd
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense		usd
CY2023	AREB	Total Finance Lease Expense TotalFinanceLeaseExpense		usd
CY2022	AREB	Total Finance Lease Expense TotalFinanceLeaseExpense		usd
CY2023	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability		usd
CY2022	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability		usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths		usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo		usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree		usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour		usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive		usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive		usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive		usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue		usd
CY2023Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount		usd
CY2023Q4	AREB	Finance Lease Liabilities FinanceLeaseLiabilities		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-41267
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Entity Registrant Name EntityRegistrantName	AMERICAN REBEL HOLDINGS, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-3892903
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	909 18th Avenue South
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite A
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Nashville
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	TN
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	37212
CY2023	dei	City Area Code CityAreaCode	(833)
CY2023	dei	Local Phone Number LocalPhoneNumber	267-3235
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	15705174	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5947643	shares
CY2023	dei	Auditor Name AuditorName	BF Borgers CPA PC
CY2023	dei	Auditor Firm AuditorFirmId	5041
CY2023	dei	Auditor Location AuditorLocation	Lakewood, CO
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1147696	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	356754	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	2816541	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	1613489	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	190933	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	207052	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	5787993	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	7421696	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	315083	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	309684	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	10258246	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	9908675	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	360495	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	456525	usd
CY2023Q4	us-gaap	Deposit Assets DepositAssets	83400	usd
CY2022Q4	us-gaap	Deposit Assets DepositAssets	18032	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1946567	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1977329	usd
CY2023Q4	us-gaap	Goodwill Goodwill	2000000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	4200000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4029967	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6195361	usd
CY2023Q4	us-gaap	Assets Assets	14648708	usd
CY2022Q4	us-gaap	Assets Assets	16560561	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1978768	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	2305077	usd
CY2023Q4	AREB	Accrued Expense And Other AccruedExpenseAndOther	271076	usd
CY2022Q4	AREB	Accrued Expense And Other AccruedExpenseAndOther	322393	usd
CY2023Q4	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	45332	usd
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	1954214	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	602643	usd
CY2023Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1456929	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1039081	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	992496	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6745400	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4222609	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	907486	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	984833	usd
CY2023Q4	us-gaap	Liabilities Liabilities	7652886	usd
CY2022Q4	us-gaap	Liabilities Liabilities	5207442	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	200000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	200000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	175000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	175000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9004920	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9004920	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	677221	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	677221	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	9005	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	677	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	52200211	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	45465077	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-45213594	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-34112810	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	6995822	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	11353119	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14648708	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16560561	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16228310	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8449800	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	13191886	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	6509382	usd
CY2023	us-gaap	Gross Profit GrossProfit	3036424	usd
CY2022	us-gaap	Gross Profit GrossProfit	1940418	usd
CY2023	AREB	Consulting Payroll And Other Payroll Costs ConsultingPayrollAndOtherPayrollCosts	3347070	usd
CY2022	AREB	Consulting Payroll And Other Payroll Costs ConsultingPayrollAndOtherPayrollCosts	905843	usd
CY2023	AREB	Officerl Compensation Expense OfficerlCompensationExpense	518107	usd
CY2022	AREB	Officerl Compensation Expense OfficerlCompensationExpense	1094781	usd
CY2023	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	1413000	usd
CY2023	AREB	Rental Expense Warehousing Outlet Expense RentalExpenseWarehousingOutletExpense	871032	usd
CY2022	AREB	Rental Expense Warehousing Outlet Expense RentalExpenseWarehousingOutletExpense	508527	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	132528	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	746871	usd
CY2023	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	1273012	usd
CY2022	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	507503	usd
CY2023	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	3317082	usd
CY2022	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	3190092	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	104229	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	50087	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	10976060	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	7003704	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-7939636	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-5063286	usd
CY2023	us-gaap	Interest Expense InterestExpense	406252	usd
CY2022	us-gaap	Interest Expense InterestExpense	358689	usd
CY2022	AREB	Interest Expense Preemptive Rights Release InterestExpensePreemptiveRightsRelease	350000	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	3780	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	5578	usd
CY2023	AREB	Employee Retention Credit Funds Net Of Costs To Collect EmployeeRetentionCreditFundsNetOfCostsToCollect	1113337	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	1900	usd
CY2023	AREB	Tangible Asset Valuation Adjustment TangibleAssetValuationAdjustment	1570816	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	2525000	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	221903	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1376756	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11100784	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7143153	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-11100784	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-7143153	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.81
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.81
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-23.90
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-23.90
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2912100	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2912100	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	298800	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	298800	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-4170337	usd
CY2022	us-gaap	Stock Issued During Period Shares Reverse Stock Splits StockIssuedDuringPeriodSharesReverseStockSplits	5140	shares
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	9038456	usd
CY2022	AREB	Common Stock Issuance Price Per Share CommonStockIssuancePricePerShare	103.75
CY2022	AREB	Stock Issued During Period Of Common Stock Issued To Pay Expense StockIssuedDuringPeriodOfCommonStockIssuedToPayExpense	969535	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	1566559	usd
CY2022Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	27.75
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	565335	usd
CY2022	AREB	Adjustments To Additional Paid In Capital Sale Of Prefunded Common Stock Warrants AdjustmentsToAdditionalPaidInCapitalSaleOfPrefundedCommonStockWarrants	12322542	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-1972578	usd
CY2022	AREB	Common Stock Compensation Price Per Share CommonStockCompensationPricePerShare	15.25
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	61000	usd
CY2022	AREB	Stock Issued During Period Value Exercise Of Prefunded Warrants StockIssuedDuringPeriodValueExerciseOfPrefundedWarrants	112025	usd
CY2022	AREB	Stock Issued During Period Value Exercise Of Prefunded Warrants1 StockIssuedDuringPeriodValueExerciseOfPrefundedWarrants1	3775	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-7143153	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	11353119	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	11353119	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	312452	usd
CY2023	AREB	Adjustments To Additional Paid In Capital Sale Of Prefunded Common Stock Warrants AdjustmentsToAdditionalPaidInCapitalSaleOfPrefundedCommonStockWarrants	2681400	usd
CY2022	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	10349964	usd
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	6150	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	115798	usd
CY2023	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	45332	usd
CY2022	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-81506	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-529324	usd
CY2023	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	100	shares
CY2023	AREB	Warrant Inducement Shares Exercised WarrantInducementSharesExercised	2988687	shares
CY2023Q4	AREB	Class Of Warrant Inducement Exercise Price Of Warrants Or Rights1 ClassOfWarrantInducementExercisePriceOfWarrantsOrRights1	1.10
CY2023	AREB	Stock Issued During Period Value Warrant Inducement And Exercise Of Repriced Common Stock Warrants Per Share StockIssuedDuringPeriodValueWarrantInducementAndExerciseOfRepricedCommonStockWarrantsPerShare	3287556	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	453756	usd
CY2023	AREB	Stock Issued During Period Value Exercise Of Prefunded Warrants StockIssuedDuringPeriodValueExerciseOfPrefundedWarrants	6150	usd
CY2023	AREB	Common Stock Compensation Price Per Share CommonStockCompensationPricePerShare	0.78
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2904	usd
CY2023	AREB	Common Stock Compensation Three Related Parties Price Per Share CommonStockCompensationThreeRelatedPartiesPricePerShare	0.78
CY2023	AREB	Stock Issued During Period Value Share Based Compensation One StockIssuedDuringPeriodValueShareBasedCompensationOne	4984	usd
CY2023	AREB	Common Stock Compensation Independent Members Board Of Directors Related Parties Price Per Share CommonStockCompensationIndependentMembersBoardOfDirectorsRelatedPartiesPricePerShare	0.75
CY2023	AREB	Stock Issued During Period Value Share Based Compensation Two StockIssuedDuringPeriodValueShareBasedCompensationTwo	18096	usd
CY2023	AREB	Stock Issued During Period Value Share Based Compensation Three StockIssuedDuringPeriodValueShareBasedCompensationThree	25	usd
CY2023	AREB	Stock Issued During Period Value Share Based Compensation Four StockIssuedDuringPeriodValueShareBasedCompensationFour	4612500	usd
CY2023	AREB	Stock Issued During Period Value Equivalents From Modification Of Stock Conversion Rights StockIssuedDuringPeriodValueEquivalentsFromModificationOfStockConversionRights	17505000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1413000	usd
CY2023	AREB	Stock Issued During Period Value Unvested Shares Reserved Through Deferred Compensation StockIssuedDuringPeriodValueUnvestedSharesReservedThroughDeferredCompensation	-22117500	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-11100784	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	6995822	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	6995822	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-11100784	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-7143153	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	104229	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	50087	usd
CY2023	AREB	Gain On Disposition Of Property GainOnDispositionOfProperty	1900	usd
CY2022	AREB	Gain On Disposition Of Property GainOnDispositionOfProperty	1994	usd
CY2023	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	2904	usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	1030535	usd
CY2023	AREB	Compensation Paid Through Issuance Of Common Stock Related Parties CompensationPaidThroughIssuanceOfCommonStockRelatedParties	23080	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1000457	usd
CY2023	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	1413000	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	2525000	usd
CY2023	AREB	Inventory Adjustment InventoryAdjustment	1570816	usd
CY2023	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	1203052	usd
CY2022	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-613104	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	49428	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	34286	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-57488	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2292844	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-544784	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	167362	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-50042	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7036069	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6828136	usd
CY2023	us-gaap	Payments To Acquire Business Two Net Of Cash Acquired PaymentsToAcquireBusinessTwoNetOfCashAcquired	325000	usd
CY2022	us-gaap	Payments To Acquire Business Two Net Of Cash Acquired PaymentsToAcquireBusinessTwoNetOfCashAcquired	10247420	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6300	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	20888	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-331300	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10268308	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	9603791	usd
CY2023	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	2833800	usd
CY2023	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	2464530	usd
CY2023	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	1700000	usd
CY2023	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	243071	usd
CY2023	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	2000000	usd
CY2022	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	60000	usd
CY2023	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	648430	usd
CY2022	AREB	Repayments Of Non Related Party Debt RepaymentsOfNonRelatedPartyDebt	2612456	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8158311	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	17435591	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	790942	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	339147	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	356754	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	17607	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1147696	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	356754	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	415472	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	270146	usd
CY2023	us-gaap	Stock Issued1 StockIssued1	4612500	usd
CY2023	AREB	Modification Of Conversion Terms ModificationOfConversionTerms	17505000	usd
CY2022	AREB	Debt Repayment Through Issuance Of Common Stock DebtRepaymentThroughIssuanceOfCommonStock	2011224	usd
CY2023	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2014-12-15
CY2023	us-gaap	Marketing Expense MarketingExpense	1273012	usd
CY2022	us-gaap	Marketing Expense MarketingExpense	507503	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.81
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.81
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-23.90
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-23.90
CY2023	AREB	Shares Used In Computation Of Basic Earnings Per Share SharesUsedInComputationOfBasicEarningsPerShare	2912100	shares
CY2022	AREB	Shares Used In Computation Of Basic Earnings Per Share SharesUsedInComputationOfBasicEarningsPerShare	298800	shares
CY2023	AREB	Total Dilutive Effect Of Outstanding Stock Awards Or Common Stock Equivalents TotalDilutiveEffectOfOutstandingStockAwardsOrCommonStockEquivalents	11909000	shares
CY2022	AREB	Total Dilutive Effect Of Outstanding Stock Awards Or Common Stock Equivalents TotalDilutiveEffectOfOutstandingStockAwardsOrCommonStockEquivalents	674600	shares
CY2023	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	14821100	shares
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	973400	shares
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-11100784	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-7143153	usd
CY2023	AREB	Fully Diluted Income Loss Per Share FullyDilutedIncomeLossPerShare	-0.75
CY2022	AREB	Fully Diluted Income Loss Per Share FullyDilutedIncomeLossPerShare	-7.34
CY2023	us-gaap	Income Tax Examination Description IncomeTaxExaminationDescription	less than a 50% likelihood
CY2022	us-gaap	Income Tax Examination Description IncomeTaxExaminationDescription	less than a 50% likelihood
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84B_eus-gaap--UseOfEstimates_zoaom0OvXCQf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_867_zGQc1uTD6mx2">Use of estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	AREB	Warranty Liability WarrantyLiability	82238	usd
CY2022Q4	AREB	Warranty Liability WarrantyLiability	93458	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-11100784	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-7143153	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-45213594	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-34112810	usd
CY2023Q4	AREB	Working Capital WorkingCapital	4551927	usd
CY2022Q4	AREB	Working Capital WorkingCapital	6678562	usd
CY2023Q4	us-gaap	Inventory Adjustments InventoryAdjustments	1570816	usd
CY2023	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	3700000	usd
CY2023	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	20000000.0	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	5787993	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	7421696	usd
CY2023Q4	AREB	Inventory Deposits And Other InventoryDepositsAndOther	315084	usd
CY2022Q4	AREB	Inventory Deposits And Other InventoryDepositsAndOther	309684	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	6103077	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	7731380	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1570816	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	789038	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	815859	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	428543	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	359334	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	360495	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	456525	usd
CY2023	us-gaap	Depreciation Depreciation	104229	usd
CY2022	us-gaap	Depreciation Depreciation	50087	usd
CY2023Q4	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P60M
CY2023Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1456929	usd
CY2023Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1456929	usd
CY2023Q4	us-gaap	Debt Current DebtCurrent	600000	usd
CY2022Q4	us-gaap	Debt Current DebtCurrent	600000	usd
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	1954214	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	602643	usd
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	1954214	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	602643	usd
CY2023Q3	AREB	Working Capital Loan WorkingCapitalLoan	600000	usd
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	1954214	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	602643	usd
CY2023Q4	us-gaap	Goodwill Goodwill	2000000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	4200000	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	2525000	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	2525000	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	2525000	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	4525000	usd
CY2023Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	2000000.0	usd
CY2022Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	4200000	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	45213594	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	34112810	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	9494850	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	7163690	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	9494850	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	7163690	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	9494850	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7163690	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	9494850	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7163690	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Explanation Of Change ValuationAllowanceDeferredTaxAssetExplanationOfChange	As a result, management determined it was more likely than not deferred tax assets will not be realized as of December 31, 2023 and December 31, 2022 and recognized 100% valuation allowance for each period
CY2023	AREB	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rates EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates	0.210	pure
CY2022	AREB	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rates EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates	0.210	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.0000	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.0000	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.210	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.210	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	463195	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-25
CY2023	AREB	Stock Issued During Period Shares Warrant Inducement And Exercise Of Repriced Common Stock Warrants Per Share StockIssuedDuringPeriodSharesWarrantInducementAndExerciseOfRepricedCommonStockWarrantsPerShare	2988687	shares
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2902.38	usd
CY2023Q3	AREB	Gain On Settlement Of Debt GainOnSettlementOfDebt	228000	usd
CY2023Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	24129	shares
CY2023Q4	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	0.225
CY2023Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.12	pure
CY2022Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	129.6875
CY2022Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1566659.00	usd
CY2022Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	15099	shares
CY2022Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	15099	shares
CY2022Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	129.6875
CY2022Q3	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	12887976.31	usd
CY2022Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	20372	shares
CY2022Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	448096	shares
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	27.50
CY2023Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.25
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.25
CY2023Q2	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	2993850.63	shares
CY2023Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	71499	shares
CY2023Q2	us-gaap	Share Price SharePrice	4.37
CY2023Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	615000	shares
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	4.37
CY2023	AREB	Stock Issued During Period Shares Warrant Inducement And Exercise Of Repriced Common Stock Warrants Per Share StockIssuedDuringPeriodSharesWarrantInducementAndExerciseOfRepricedCommonStockWarrantsPerShare	2988687	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	28071	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	220.00
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y11M12D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	116386	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	129.6875
CY2022	AREB	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2	P5Y
CY2022	AREB	Share Based Payment Award Options Granted Debt Conversion ShareBasedPaymentAwardOptionsGrantedDebtConversion	15099	shares
CY2022	AREB	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Granted Debt Conversion Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantedDebtConversionExercisePrice	129.6875
CY2022	AREB	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Granted Debt Conversion Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualGrantedDebtConversionTerm2	P5Y
CY2022	AREB	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Warrant ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWarrant	463195	shares
CY2022	AREB	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Warrant Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageWarrantExercisePrice	0.25
CY2022	AREB	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Warrant Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualWarrantTerm2	P5Y
CY2022	AREB	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period One ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodOne	936937	shares
CY2022	AREB	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price One ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceOne	21.50
CY2022	AREB	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1	P5Y
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.25
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations	38	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	1096455	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	30.50
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y6M
CY2023	AREB	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Warrant ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWarrant	615000	shares
CY2023	AREB	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Warrant Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageWarrantExercisePrice	4.37
CY2023	AREB	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Warrant Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualWarrantTerm2	P5Y
CY2023	AREB	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period One ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodOne	686499	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	4.24
CY2023	AREB	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2	P5Y
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Other ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther	1365251	shares
CY2023	AREB	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Repricing Transaction ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRepricingTransaction	1.10
CY2023	AREB	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term3 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm3	P4Y
CY2023	AREB	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted New Warrant ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedNewWarrant	5977374	shares
CY2023	AREB	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Granted Agreement New Warrants ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantedAgreementNewWarrants	1.10
CY2023	AREB	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term4 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm4	P5Y
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	3603687	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.88
CY2023	AREB	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Exercised Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageExercisedRemainingContractualTerm2	P5Y
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.15
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y8M12D
CY2023	AREB	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Granted Agreement New Warrants ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantedAgreementNewWarrants	1.10
CY2023	AREB	Rent Expense For Operating Leases RentExpenseForOperatingLeases	1214000	usd
CY2022	AREB	Rent Expense For Operating Leases RentExpenseForOperatingLeases	502000	usd
CY2023	AREB	Rental Equipment Expense For Finance Leases RentalEquipmentExpenseForFinanceLeases	0	usd
CY2022	AREB	Rental Equipment Expense For Finance Leases RentalEquipmentExpenseForFinanceLeases	0	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	1214681	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	502421	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	1214681	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	502421	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1946567	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1977329	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	1101797	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	1038647	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y
CY2023Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P0Y
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P0Y
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1000	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0500	pure
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1239855	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	407861	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	291375	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	258282	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	194262	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2391634	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	286669	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2104965	usd
CY2023	us-gaap	Payments For Rent PaymentsForRent	1214681	usd
CY2022	us-gaap	Payments For Rent PaymentsForRent	502421	usd
CY2023Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	0	usd
CY2022Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	0	usd
CY2023Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1456929	usd
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001493152-24-014473-index-headers.html	Edgar Link	pending
0001493152-24-014473-index.html	Edgar Link	pending
0001493152-24-014473.txt	Edgar Link	pending
0001493152-24-014473-xbrl.zip	Edgar Link	pending
areb-20231231.xsd	Edgar Link	pending
ex10-22.htm	Edgar Link	pending
ex10-23.htm	Edgar Link	pending
ex10-24.htm	Edgar Link	pending
ex14-2.htm	Edgar Link	pending
ex21-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
ex4-4.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
areb-20231231_cal.xml	Edgar Link	unprocessable
areb-20231231_def.xml	Edgar Link	unprocessable
areb-20231231_lab.xml	Edgar Link	unprocessable
areb-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AREB
AMERICAN REBEL HOLDINGS INC Stock $areb

2024 Q2 Form 10-K Financial Statement

#000149315224014473 Filed on April 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AREB AMERICAN REBEL HOLDINGS INC Stock $areb

2024 Q2 Form 10-K Financial Statement

#000149315224014473 Filed on April 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AREB
AMERICAN REBEL HOLDINGS INC Stock $areb